“I think of myself as a culture and leadership alchemist,” says Amy Pooser, president and chief operating officer of Convene, a leading tech-enabled hospitality company that is reimagining what a “workday” means for today’s most innovative companies. Convene accomplishes this by providing inspiring spaces, premium hospitality, and the hybrid technology that firms need to grow. Pooser says her mission is to elevate the way people meet, work, and live through what she calls a “people-first” approach.

For Maria Martinez, the future of work has never looked particularly bright. In most of her 25 years as a dishwasher at a DoubleTree by Hilton hotel in Southern California, she had never gotten a raise beyond the minimum wage hikes mandated by the government. Before the pandemic hit, there were three people helping with her shift. Now, it’s often just her. Martinez keeps asking her bosses for help — business at the hotel has picked back up again — but for the moment, they’re not really budging.

The covid-19 pandemic is still not over. And while injected vaccines provide good protection from severe disease, they don’t stop us from catching the virus or spreading it to others. 

Vaccines that you inhale through the nose or mouth, on the other hand, potentially could.

In the last week, regulatory bodies in both India and China have approved inhaled vaccines for covid-19. The companies behind these vaccines say that they’ll boost the immune responses of people who have already been vaccinated. Here’s what we know so far.